Hims & Hers Health, Inc.

Hims & Hers Health, Inc. (NYSE: HIMS) is a direct-to-consumer telehealth company that completed its SPAC merger in January 2021, combining with Oaktree Acquisition Corp, a blank-check vehicle sponsored by Oaktree Capital Management. The company, which offers personalized health and wellness products across categories including sexual health, dermatology, and mental health, has been publicly traded since that merger closed. The 8-K filed on June 17, 2025, reflects the company's continued activity as a reporting issuer in the consumer healthcare and telehealth sector. Sign up at SpacDesk to access the full filing history, SPAC deal metrics, and real-time data for HIMS and hundreds of other de-SPAC companies.